2006
DOI: 10.1002/jps.20584
|View full text |Cite
|
Sign up to set email alerts
|

A Risk-Based Approach to Establish Stability Testing Conditions for Tropical Countries

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
9
0

Year Published

2007
2007
2016
2016

Publication Types

Select...
4
3
1

Relationship

0
8

Authors

Journals

citations
Cited by 15 publications
(9 citation statements)
references
References 3 publications
0
9
0
Order By: Relevance
“…This was a risk-based assessment where we identified pharmaceutical quality issues with a higher risk profile [17, 22]. Unlike comprehensive quality assessments that include dissolution and impurity testing, we focused specifically on the identity and content of the medicines circulating in the retail pharmaceutical market in Tanzania to inform regulators and public health stakeholders of areas that need attention.…”
Section: Resultsmentioning
confidence: 99%
“…This was a risk-based assessment where we identified pharmaceutical quality issues with a higher risk profile [17, 22]. Unlike comprehensive quality assessments that include dissolution and impurity testing, we focused specifically on the identity and content of the medicines circulating in the retail pharmaceutical market in Tanzania to inform regulators and public health stakeholders of areas that need attention.…”
Section: Resultsmentioning
confidence: 99%
“…By using 14 C-OVA as a tracer, we measured that 248±29 ng influenza vaccine was delivered to each mouse. The storage temperature was following WHO guidelines [33]. Then, at months 0, 1, 2, 3 and 6, ten of the coated patches were used to immunize groups of five C57BL/6 mice.…”
Section: Vaccination Of Micementioning
confidence: 99%
“…First, as one test case, influenza vaccine dry-coated NPs are stable for at least 6 months at 23 ºC, so there is a potential to remove the huge burden of cold chain in vaccination campaign in temperate and subtropical regions [33]. Second, associated with targeted delivery of influenza vaccines to thousands of skin's APCs, the NP achieves unprecedented dose sparing (30 fold).…”
Section: Potential Utility Of Np In Low-resource Regionsmentioning
confidence: 99%
“…lation development. 2,4,7,33 This study shows that probably not all manufacturers comply with this requirement. This is in line with the idea that substandard drug cases are under-reported and are often confused with counterfeit drugs, causing limited understanding of the extent of the problem.…”
Section: Discussionmentioning
confidence: 87%